Dear Colleagues,
We are here again with a new issue and some news. We will be happy to give you a good news. Viral Hepatitis Journal began to indexed in Emerging Sources Citation Index (SCI-E). Your articles that published in our journal along with this number will be indexed in Emerging Sources Citation Index (ESCI).
In this ıssue, there are one review article about “Chronic Viral Hepatitis in Human Immunodeficiency Virus-infected Patients” and four articles about
“Telaprevir-based Triple Therapy for Retreatment of Chronic Hepatitis C Patients with Genotype Four Followed in Our Clinic”, “Can Detection of Non- alcoholic Fatty Liver Disease be Coincidental in Young Patients with Chronic Hepatitis B?“ “The Frequency of Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus Infections among Patients with Schizophrenia in a Mental Health Hospital in Turkey”, “Red Cell Volume Distribution Width to Platelet Ratio is an Important Predictor of Liver Fibrosis and Cirrhosis in Chronic Hepatitis B”.
Also; “Seroprevalence Rates of Hepatitis B Surface Antigen, Anti-Hepatitis C Virus and Anti-Human Immunodeficiency Virus ½ Certain Risk Groups”,
“Seroprevalence of Hepatitis B Virus, Hepatitis C Virus and Human Immunodeficiency Virus among Healthcare Staff in a State Hospital” and
“Liver Biopsy is the Gold Standard at Present, How about Tomorrow?”, subjects were included in the Letter to editor in this issue.
We expect your contributions with articles, case reports, reviews, and letters to editor.
Best wishes
Prof. Dr. Fehmi TABAK Prof. Dr. Mustafa ALTINDİŞ
EDITORIAL
A-VIII
VIRAL HEPATITIS SOCIETY
